BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 9615793)

  • 1. MiR-376a-3p increases cell apoptosis in acute myeloid leukemia by targeting MT1X.
    Xin X; Xu Z; Wei J; Zhang Y
    Cancer Biol Ther; 2022 Dec; 23(1):234-242. PubMed ID: 35316152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of metallothioneins in carcinogenesis.
    Si M; Lang J
    J Hematol Oncol; 2018 Aug; 11(1):107. PubMed ID: 30139373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PU.1 suppressive target gene, metallothionein 1G, inhibits retinoic acid-induced NB4 cell differentiation.
    Hirako N; Nakano H; Takahashi S
    PLoS One; 2014; 9(7):e103282. PubMed ID: 25072246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular functions of metallothionein and its role in hematological malignancies.
    Takahashi S
    J Hematol Oncol; 2012 Jul; 5():41. PubMed ID: 22839501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells.
    Imoto A; Okada M; Okazaki T; Kitasato H; Harigae H; Takahashi S
    J Biol Chem; 2010 Apr; 285(14):10300-9. PubMed ID: 20139074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multidrug resistance in the treatment of cancer].
    Kuitunen T; Pyrhönen S
    Duodecim; 1991; 107(22):1846-51. PubMed ID: 1365962
    [No Abstract]   [Full Text] [Related]  

  • 7. Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse.
    Massaad-Massade L; Ribrag V; Marie JP; Faussat AM; Bayle C; Dreyfus F; Gouyette A
    Anticancer Res; 1997; 17(6D):4647-51. PubMed ID: 9494583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase in childhood acute non-lymphoblastic leukemia.
    Volm M; Zintl F; Sauerbrey A
    Anticancer Res; 1994; 14(3B):1271-5. PubMed ID: 8067695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of resistance proteins in initial acute lymphatic leukemia (ALL) in childhood].
    Sauerbrey A; Volm M; Zintl F
    Klin Padiatr; 1995; 207(4):230-4. PubMed ID: 7564159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL).
    Sauerbrey A; Zintl F; Hermann J; Volm M
    Anticancer Res; 1998; 18(2B):1231-6. PubMed ID: 9615793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance of acute leukemia and a strategy to overcome it.
    Motoji T; Motomura S; Wang YH
    Int J Hematol; 2000 Dec; 72(4):418-24. PubMed ID: 11197207
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.